OpenAlex
PricingAboutJobs
Log inGet started
Work

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

HTML

Year: 1987
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.1987.5.9.1430
Authors: N K Cheung, H Lazarus, F D Miraldi, C R Abramowsky, S Kallick, U M Saarinen, T Spitzer, S E Strandjord, P F Coccia, N A Berger
Institution: Memorial Sloan Kettering Cancer Center
Language: English

Topic: Neuroblastoma Research and Treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: GD2, neuroblastoma, melanoma, complement activation, antibody-dependent cellular cytotoxicity, metastatic disease, serum antibody levels, complement depletion, antitumor immunity
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: NEUROBLASTOMA ANTIBODIES FOR DIAGNOSIS AND TREATMENT
OpenAlex ID: W1951179504
FWCI: 14.78
Cites: 17
Cited by: 434
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms